Latest Breaking News On - Us medical affairs at bayer healthcare pharmaceuticals - Page 1 : comparemela.com

/PRNewswire/ On April 17, 2023, ImmVira announced the appointment of Dr. Oliver Kong as Chief Medical Officer (CMO). Dr. Kong will be fully in charge of.

Us medical affairs at bayer healthcare pharmaceuticalsUniversity of nebraska medical centerShanghai medical college of fudan universityQilu pharmaceuticalsOliver kongChief medical officerShanghai medical collegeFudan universityMolecular immunologyNebraska medicalCorporate vice presidentVice presidentClinical oncologyHengrui therapeuticsSenior global medical leaderGlobal medical affairs